Georgia Beasley

Co-leader of the DCI Melanoma Disease Group Georgia Beasley, MD, MHSc, is among 40 recipients of a Young Physician-Scientist Award from The American Society for Clinical Investigation.

DCI's Melanoma (and advanced skin cancer) Disease Group expands Clinic 5-1 services to include dermatological cancer care for patients who require multidisciplinary care.

A decade since the first drug, an immunotherapy, was approved to treat metastatic melanoma, a leading clinician researcher goes head to head with melanoma brain metastasis.

Here are some of the DCI faculty, researchers and nurses whose work has recently been featured by the media, academic trade publications & journals.

Brent Hanks, MD, PhD, was named associate director of Translational Science for the Melanoma Disease Group this month.

Here's a sample of some of the DCI physicians, physician-scientists, researchers and nurses whose work is featured by the media and in academic journals.

Here's a sample of some of the DCI physicians, physician-scientists, researchers and nurses whose work is featured by the media and in academic journals.

Here's a sample of some of the DCI physicians, physician-scientists, researchers and nurses whose work is featured by the media and in academic journals.

Here's a sample of some of the DCI physicians, physician-scientists, researchers and nurses whose work is featured by the media and in academic journals.

Surgical oncologist and melanoma specialist Georgia Beasley, MD, MHSc, has been named co-director of Duke Cancer Institute’s Melanoma Disease Group.